PRPO logo.png
Precipio Launches Covid-19 Antibody Test in its CLIA laboratory
August 04, 2020 10:45 ET | Precipio, Inc.
NEW HAVEN, Conn., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced it has completed the internal validation of the FDA-approved COVID-19...
Interpace Biosciences Announces First Quarter 2020 Financial and Business Results
June 25, 2020 16:59 ET | Interpace Biosciences, Inc.
First Quarter Net Revenue Improved Over 53% to $9.2 Million Launching COVID-19 Serology Testing Continues to Integrate Service Offerings and Streamline Costs Conference Call and Webcast Thursday...